Skip to main content

Men Aged >16 to to <55 years at increased risk for acute kidney injury (AKI)

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 10, 2024.

via HealthDay

FRIDAY, Nov. 8, 2024 -- Boys and men aged >16 to <55 years have an increased risk for acute kidney injury (AKI) during hospitalization, according to a study published online Oct. 22 in the American Journal of Kidney Disease.

Noting that female sex hormones have been suggested to play a protective role in kidney disease, Ladan Golestaneh, M.D., from the Yale University School of Medicine in New Haven, Connecticut, and colleagues conducted a prospective cohort study to examine the strength of the association between sex and AKI incidence in hormonally distinct age groups across the life span. Data were included for all patients hospitalized in the Montefiore Health System between Oct. 15, 2015, and Jan. 1, 2019, except those with kidney failure or obstetrics diagnoses.

Overall, 132,667 individuals had 235,629 hospitalizations (55 percent of hospitalizations for women). The researchers found that 30.5 and 10.3 percent of hospitalizations occurred among Black and Hispanic patients, respectively. Overall, AKI occurred in 22.9 percent of hospitalizations. A significant interaction was seen between age and sex in adjusted models. Across all age groups, boys and men had a higher risk for AKI, with the association more pronounced for those aged >16 to <55 years, which had an odds ratio for 1.7 for men. Across prespecified types of hospitalizations, the age-based pattern persisted. A sensitivity analysis revealed that women older than 55 years who received prescriptions for estrogen had lower odds of AKI than those without prescriptions.

"Our study shows that the protection afforded by female sex is highest among menstruating women, is absent in prepubertal females and declines with the onset of menopause," Golestaneh said in a statement.

Authors disclosed ties to Axon Therapies, Horizon Therapeutics, and AstraZeneca.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department

FRIDAY, July 18, 2025 -- From 2016 to 2022, 5.3 percent of all U.S. emergency department visits were related to low back pain, with opioid administration and prescription...

ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy

FRIDAY, July 18, 2025 -- An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient...

Dogs Can Differentiate Between People With Parkinson Disease, Controls

FRIDAY, July 18, 2025 -- Dogs can differentiate between dry skin swab samples from people with Parkinson disease (PwP) and controls, according to a study published online July 14...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.